Lexington, MA, United States of America

Lianne Boeglin

This inventor holds 3 USPTO granted patents and 6 published patent applications. Top assignee: Translate Bio, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lianne Boeglin. Retrieved from https://idiyas.com/inventor/lianne-boeglin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 100.0

Average Co-Inventor Count = 4.3

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Lianne Boeglin: Innovator in mRNA Delivery Systems

Introduction

Lianne Boeglin is a prominent inventor based in Lexington, MA (US). She has made significant contributions to the field of biotechnology, particularly in the development of mRNA delivery systems. With a total of 3 patents to her name, Lianne is recognized for her innovative approaches to medical treatments.

Latest Patents

Lianne's latest patents include groundbreaking work on "Compositions for Delivery of Codon-Optimized mRNA" and "Methods for Treatment of Methylmalonic Acidemia." These patents reflect her commitment to advancing therapeutic techniques and improving patient outcomes through innovative solutions.

Career Highlights

Lianne Boeglin is currently employed at Translate Bio, Inc., where she continues to push the boundaries of mRNA technology. Her work has been instrumental in developing new methods that enhance the efficacy of mRNA therapies.

Collaborations

Throughout her career, Lianne has collaborated with notable colleagues, including Michael W. Heartlein and Frank Derosa. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Lianne Boeglin's contributions to the field of biotechnology and her innovative patents position her as a leading figure in mRNA research. Her work continues to inspire advancements in medical treatments and showcases the importance of innovation in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…